1-2 of 2
Keywords: Disease-specific survival
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Prognostic Value of T1 Bladder Cancer Substaging: A Single Institution Retrospective Study

Available to Purchase
Subject Area:
Further Areas
V. Soukup, J. Dušková, M. Pešl, O. Čapoun, Z. Feherová, L. Zámečník, T. Hanuš, M. Babjuk
Journal: Urologia Internationalis
Urol Int (2014) 92 (2): 150–156.
https://doi.org/10.1159/000355358
Published Online: 27 February 2014
...) and the number of bacillus Calmette-Guérin instillations (p = 0.0490) were significant in predicting progression. The only significant factor for disease-specific survival was T1 substaging in univariable (p = 0.0008) and multivariable (hazard ratio 4.407) analysis. T1 substaging (p = 0.0149) and tumour...
View article titled, The Prognostic Value of T1 Bladder Cancer Substaging: A Single Institution Retrospective Study
Open the PDF for The Prognostic Value of T1 Bladder Cancer Substaging: A Single Institution Retrospective Study in another window
Journal Articles

Competing Mortality Contributes to Excess Mortality in Patients with Poor-Risk Lymph Node-Positive Prostate Cancer Treated with Radical Prostatectomy

Available to Purchase
Subject Area:
Further Areas
Michael Froehner, Albrecht Scholz, Rainer Koch, Oliver W. Hakenberg, Gustavo B. Baretton, Manfred P. Wirth
Journal: Urologia Internationalis
Urol Int (2012) 89 (2): 148–154.
https://doi.org/10.1159/000339279
Published Online: 19 July 2012
...). Fig. 2 Disease-specific survival (100% minus cumulative disease-specific mortality rate; deaths from causes other than prostate cancer were considered competing events) stratified into three different risk groups by the risk factors identified in the multivariate analysis (Pepe-Mori tests: 0 vs. 1...
View article titled, Competing Mortality Contributes to Excess Mortality in Patients with Poor-Risk Lymph Node-Positive Prostate Cancer Treated with Radical Prostatectomy
Open the PDF for Competing Mortality Contributes to Excess Mortality in Patients with Poor-Risk Lymph Node-Positive Prostate Cancer Treated with Radical Prostatectomy in another window